CLINICAL_TRIALS
trial_result
· 2018-07-03
Clinical Trial Update: Linagliptin as Add on to Basal Insulin in the Elderly [Phase 4]
Summary
A Phase 4 trial evaluating adding linagliptin to basal insulin in elderly patients with type 2 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2018-07-03